pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,019 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT776Endpoints580BioPharma Dive223onclive165Fierce Biotech54BioSpace52raps24
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6
  • STAT+: Trump administration revisits policy to close Medicare drug price negotiation loophole
    Trump administration revisits policy to plug Medicare drug price negotiation loophole.
    STAT · 1mo ago↗ source
  • STAT+: Up and down the ladder: The latest comings and goings
    From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
    STAT · 1mo ago↗ source
  • STAT+: Prometheus raises $12 billion in capital for artificial engineers
    Nonprofit Blood Cancer United acquires cancer drug, Lilly and Nvidia invest in Abridge, and more biotech news
    STAT · 1mo ago↗ source
← prev
page 17 of 41
next →
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
  • STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and more
    The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta
    STAT · 1mo ago↗ source
  • Chile offers new data on food warning label efficacy
    Kennedy's "publicly" "available" "calendar," drinking during pregnancy, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • Opinion: I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule
    “American science is too valuable to be turned into a political football,” writes David J. Skorton, president of the Association of American Medical Colleges.
    STAT · 1mo ago↗ source
  • Opinion: Ebola outbreak response requires engaging with religious traditions and leaders
    “Failing to engage religious and traditional leaders in meaningful ways was a grave misstep in previous Ebola outbreaks,” researchers write.
    STAT · 1mo ago↗ source
  • STAT+: At hospital finance conference, a call to end the friction that’s keeping costs high
    Hospital execs agree that affordability is a major issue. What to do about it is less clear.
    STAT · 1mo ago↗ source
  • How a diabetes conference sparked a controversy
    Many in the diabetes research community expressed shock and disbelief that their colleagues were threatened with arrest for passing out paper copies of an editorial.
    STAT · 1mo ago↗ source
  • STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
    STAT is tracking goals and promises of Robert F. Kennedy Jr. and his Make America Healthy Again movement — successes, incompletes, and fails.
    STAT · 1mo ago↗ source
  • STAT+: An obesity drug deep-dive, and peptides move mainstream
    Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food and Drug Administration allow…
    STAT · 1mo ago↗ source
  • RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
    None of STAT's requests for Kennedy's schedule have been completed, and some haven't even been acknowledged.
    STAT · 1mo ago↗ source
  • Drinking during pregnancy rose after 2020, new CDC data suggest
    A new CDC report underscores that drinking during pregnancy, while generally thought of as a thing of the past, is still a matter of concern. 
    STAT · 1mo ago↗ source
  • STAT+: AMA and lawmakers push back on AI care denials
    In this edition of STAT Health Tech: HHS watchdog on denials by health insurers, lawmakers target AI denials, and Talkspace's new chatbot offering.
    STAT · 1mo ago↗ source
  • Nonprofit buys experimental cancer drug to maintain patient access
    In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug.
    STAT · 1mo ago↗ source
  • Study highlights influence of socioeconomic status on children’s brain development
    A new study found that the leading environmental factor influencing brain structure and function is the socioeconomic status of a child's family.
    STAT · 1mo ago↗ source
  • STAT+: Abridge inks deals with Nvidia and Lilly
    Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.
    STAT · 1mo ago↗ source
  • STAT+: A suspicious denial pattern in Medicare Advantage
    Major Medicare Advantage plans almost always reversed their denials on appeal, raising big questions about barriers to care.
    STAT · 1mo ago↗ source
  • STAT+: Novartis doubles down on molecular glue strategy
    Seniors' drug costs rise sharply, Enliven's leukemia drugs, and more biotech news from The Readout
    STAT · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more
    More employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the medications
    STAT · 1mo ago↗ source
  • STAT+: Enliven Therapeutics’ leukemia drug shows promise in new study
    A targeted drug from Enliven Therapeutics induced molecular responses in nearly half of patients with advanced leukemia, new data show.
    STAT · 1mo ago↗ source
  • STAT+: ‘Synthetic lethality’ could trigger another round of biotech M&A
    Proving out a "synthetic lethality" approach can help treat cancer will take a lot more work. It also might trigger some creative deal-making.
    STAT · 1mo ago↗ source
  • HHS responds coolly to paper on alcohol risk
    Soda and liver cancer, scientists conflicted on a new NIH proposal, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • Opinion: We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850
    In 2025, Elizabeth Selvin and her colleagues published in Nature Medicine for free. In 2026, it cost them $12,850, she writes.
    STAT · 1mo ago↗ source
  • Opinion: How long Covid’s scientific stalemate made it politically erasable
    Long Covid hasn’t disappeared. It’s just gone underground, writes Steven Phillips.
    STAT · 1mo ago↗ source